Clinical trial Recruiting at 1 site Observational Ages 2 to 40 Men only

Examining facial features in boys with creatine transporter deficiency

Official title: Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency

Run by National Institutes of Health Clinical Center (CC) · NCT05600946 · Data updated 2026-11-12

This study looks at photos of boys and young men with creatine transporter deficiency to see if they share certain facial features that could help doctors diagnose the condition more accurately.

More Autism Spectrum Disorder trials

Quick facts

Study typeObservational
Ages2 Years to 40 Years
SexMen only
Enrollment30 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedOctober 24, 2022
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT05600946 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are males aged 2 to 40 years who have a confirmed genetic mutation in the SLC6A8 gene and are enrolled in the Creatine Natural History Study.

Probably not a fit

Patients who have experienced status epilepticus within the last three months or have severe seizure disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate photographs of male subjects aged 2 to 40 years with creatine transporter deficiency (CTD) to identify common craniofacial features associated with the condition. The study involves collaboration with an expert in dysmorphology who will analyze the images to determine if specific dysmorphic traits are present in this population. By characterizing these features, the study seeks to improve diagnostic accuracy for CTD, which can often be confused with other disorders such as autism. Participants must have a confirmed genetic mutation in the SLC6A8 gene and provide informed consent.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic methods for creatine transporter deficiency, aiding in earlier and more accurate identification of affected individuals.

How similar studies have gone: While this approach is focused on dysmorphology in CTD, similar studies have shown success in identifying facial features associated with other genetic disorders, suggesting potential for meaningful findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

  1. Patient is male and between 2-40 years of age, inclusive.
  2. Patient has genomic confirmation of a pathologic mutation in the SLC6A8 gene.
  3. Patient is able to complete study-related procedures within limitations imposed by condition under study.
  4. Patients parents/guardians/caregivers must provide written consent (informed consent) to study-related procedures, and if appropriate, the patient will provide an assent.

EXCLUSION CRITERIA:

1. Patient has had status epilepticus within 3 months of screening.
2. Patients has had a seizure that lasts 5 minutes or longer, and a second seizure without recovering consciousness from the first one, or if a person has repeated seizures for 30 minutes or longer.
3. Patient is unable to comply with the study procedures or has a clinical disease or laboratory abnormality that in the opinion of the investigator would potentially increase the risk of participation.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Laverne G Mensah, M.D. — Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Study coordinator: Derek M Alexander
  • Email: derek.alexander@nih.gov
  • Phone: (301) 827-0387

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.